YUBO INTERNATIONAL BIOTECH LIMITED (YBGJ) Total liabilities 2018–2025
YUBO INTERNATIONAL BIOTECH LIMITED (YBGJ) total liabilities at each fiscal year-end, per SEC filings.
$2.8MFY2025 · since FY2018: $1.7M → $2.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $2.8M | -42.2% |
| FY2024 | $4.8M | +37.6% |
| FY2023 | $3.5M | +20.5% |
| FY2022 | $2.9M | -38.2% |
| FY2021 | $4.7M | — |
| FY2019 | $1.8M | +7.9% |
| FY2018 | $1.7M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More YBGJ financial trends
YBGJ RevenueYBGJ Net incomeYBGJ Net marginYBGJ Gross profitYBGJ Gross marginYBGJ Operating incomeYBGJ Operating marginYBGJ Operating cash flowYBGJ Free cash flowYBGJ Capital expendituresYBGJ Return on equityYBGJ Stock buybacksYBGJ Dividends paidYBGJ Total assetsYBGJ Shareholders’ equityYBGJ overview →